jyoung
09-21-2009, 08:57 PM
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 2.09% in the opening trade. The stock is trading at $10.23 with a huge volume of 2.4 million shares. The yield till date of the stock in this calendar year is 721.01%. Today September 21, 2009 BioCryst Pharmaceuticals, Inc. announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza………..
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!